Description
| Item ID # | 12548900 |
| Manufacturer # | 1254804 |
| Brand | |
Antimuscarinic / Antispasmodic Ipratropium Bromide 0.02%, 0.2 mg / mL Unit Dose, Inhalation Solution Vial 25 Vials
UOM CARTON/25
$5.77
10000 in stock
Related products
-
#58908900 Mfr# 589-05Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
- Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
- Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
-
#18298900 Mfr# 49281-400-10Adacel® TDaP Vaccine Age 11 to 64 Years of Age Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed, Preservative Free Injection Single Dose Vial 0.5 mL
Features
- ADACEL vaccine is indicated for active booster immunization for the prevention of tetanus, diphtheria, and pertussis as a single dose in people 11 through 64 years of age
-
#47718900 Mfr#Beta-Adrenergic Agonist Albuterol Sulfate 0.083%, 2.5 mg / 3 mL Unit Dose, Inhalation Solution Nebulizer Vial 30 Vials
Item ID # 47718900 Manufacturer # 2434801 Brand -
#58908900 Mfr#
Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
- Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
- Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart